Clinical trials recruiting in Al-Ahsa, Saudi Arabia

Phase breakdown

Conditions recruiting in Al-Ahsa, Saudi Arabia

Recruiting trials in Al-Ahsa, Saudi Arabia

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
  NCT07613307 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Al-Ahsa, Saudi Arabia?

3 recruiting trials have at least one study site in Al-Ahsa, Saudi Arabia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.